During the past decade, Hegau-Bodensee Klinikum Singen conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hegau-Bodensee Klinikum Singen" #1 sponsor was "Amgen" with 1 trials, followed by "Biotronik SE & Co. KG" with 1 trials sponsored, "CeloNova BioSciences, Inc." with 1 trials sponsored, "IHF GmbH - Institut für Herzinfarktforschung" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hegau-Bodensee Klinikum Singen" #1 collaborator was "Dr. Köhler Chemie (Alsbach-Hähnlein, Germany)" with 1 trials as a collaborator, "Ferrer Internacional S.A." with 1 trials as a collaborator, "GEA (Frederiksberg, Denmark)" with 1 trials as a collaborator, "HP-Medica (Augsburg, Germany)" with 1 trials as a collaborator and "Kardialagut (München, Germany)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hegau-Bodensee Klinikum Singen" are "Acute Myocardial Infarction" (1 trials), "Angina, Stable" (1 trials), "Angina, Unstable" (1 trials), "Anticoagulants" (1 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Hegau-Bodensee Klinikum Singen" in a lesser frequency.

Most popular intervention types in "Hegau-Bodensee Klinikum Singen" are "Device" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Archival Tumor Tissue Sample" (1 trials), "COBRA PzF" (1 trials), "Drug Eluting Stent" (1 trials), "Ilivia ICD Family" (1 trials) and "Lp(a) Screening" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hegau-Bodensee Klinikum Singen" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Hegau-Bodensee Klinikum Singen". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hegau-Bodensee Klinikum Singen, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hegau-Bodensee Klinikum Singen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Hegau-Bodensee Klinikum Singen has several departments that took part in Clinical trials: "Studienzentrum der Inneren Medizin I & II am Klinikum Konstanz" - 2 trials